Form 8-K - Current report:
SEC Accession No. 0000942794-00-000038
Filing Date
2000-08-22
Accepted
2000-08-22 00:00:00
Documents
1
Period of Report
2000-08-22
Items
Item 1: Changes in control of registrant

Document Format Files

Seq Description Document Type Size
1 0001.txt 8-K 9505
  Complete submission text file 0000942794-00-000038.txt   11355
Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address 175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK FRAMINGHAM MA 01702 5087975777
AQUILA BIOPHARMACEUTICALS INC (Filer) CIK: 0000704292 (see all company filings)

EIN.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12081 | Film No.: 707424
SIC: 2835 In Vitro & In Vivo Diagnostic Substances